Recently, Japan announced a groundbreaking discovery that could extend cats’ lives by up to 15 years. A team led by former Tokyo University professor Takaaki Miyazaki developed a drug that combats chronic kidney disease, a common issue in aging cats. The drug helps restore the function of a protein called AIM, which clears waste from the kidneys. After initial funding challenges, the project gained massive public support, raising 3 billion yen. The drug is expected to hit the market within two years, potentially extending cats’ lifespans from 15 to 30 years.

In an interview, Professor Miyazaki said, “Our goal was always to help cats live longer, healthier lives. Seeing severely ill cats regain their energy and mobility is truly rewarding.” He continued, “With the backing of so many pet owners, we feel a huge responsibility to bring this drug to market as soon as possible.”

In a comment on Weibo, one cat owner involved in the trial shared their experience: “I was told my cat had only a week left, but after the treatment, she started walking again and even playing. It’s like a miracle!”

Another cat owner on our campus was very excited about this information.

She said, “It’s truly unbelievable! What used to just be wishful thinking might actually come true. My cat has been the most important companion in my life, and I’d be devastated if he wasn’t there when I needed him the most. I really hope this drug becomes available in the U.S. soon.”

The drug is currently in clinical trials and is expected to be available to the public by 2025. Many cat owners eagerly await its release, hoping it will help them spend many more years with their beloved pets.